Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
NAD+ therapy (injections/IVs) excels, boosting levels, mitochondrial function, and energy.[20][21] Clinical evidence shows improvements in fatigue and metabolic markers, with some studies reporting enhanced quality of life
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Visits are calm and efficient
Over the years, research and development have improved the reliability and affordability of this technology, making it more accessible
